Literature DB >> 11123049

Sleep and circadian rhythm disorders in fibromyalgia.

A Korszun1.   

Abstract

Fibromyalgia (FM) is a syndrome of generalized muscle pain that is also associated with equally distressing symptoms of sleep disturbance and fatigue. FM shows clinical overlap with other stress-associated disorders, including chronic fatigue syndrome (CFS) and depression. All of these conditions have the features of disrupted sleep patterns and dysregulated biologic circadian rhythms, such as stress hormone secretion. This review focuses on the role of sleep and circadian rhythm disorders in FM and, in the absence of any specific treatment for FM, presents a pragmatic therapeutic approach aimed at identifying and treating comorbid sleep and depressive disorders, optimizing sleep habits, and judicious use of pharmacologic agents.

Entities:  

Mesh:

Year:  2000        PMID: 11123049     DOI: 10.1007/s11926-000-0052-4

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  31 in total

1.  Musculosketal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects.

Authors:  H Moldofsky; P Scarisbrick; R England; H Smythe
Journal:  Psychosom Med       Date:  1975 Jul-Aug       Impact factor: 4.312

2.  Guidelines for the diagnosis and treatment of depression for primary care physicians. Implications for consultation-liaison psychiatrists.

Authors:  R Kathol; W Katon; G R Smith; F Petty; M Trivedi; A J Rush
Journal:  Psychosomatics       Date:  1994 Jan-Feb       Impact factor: 2.386

3.  Melatonin levels in women with fibromyalgia and chronic fatigue syndrome.

Authors:  A Korszun; L Sackett-Lundeen; E Papadopoulos; C Brucksch; L Masterson; N C Engelberg; E Haus; M A Demitrack; L Crofford
Journal:  J Rheumatol       Date:  1999-12       Impact factor: 4.666

Review 4.  Neurohormonal perturbations in fibromyalgia.

Authors:  L J Crofford; N C Engleberg; M A Demitrack
Journal:  Baillieres Clin Rheumatol       Date:  1996-05

5.  Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia.

Authors:  G Affleck; S Urrows; H Tennen; P Higgins; M Abeles
Journal:  Pain       Date:  1996-12       Impact factor: 6.961

6.  Sleep, daytime symptoms, and cognitive performance in patients with fibromyalgia.

Authors:  K A C-oté; H Moldofsky
Journal:  J Rheumatol       Date:  1997-10       Impact factor: 4.666

7.  Sleep and other symptoms in primary fibromyalgia and in healthy controls.

Authors:  P Jennum; A M Drewes; A Andreasen; K D Nielsen
Journal:  J Rheumatol       Date:  1993-10       Impact factor: 4.666

8.  Fibromyalgia--a syndrome associated with decreased nocturnal melatonin secretion.

Authors:  J Wikner; U Hirsch; L Wetterberg; S Röjdmark
Journal:  Clin Endocrinol (Oxf)       Date:  1998-08       Impact factor: 3.478

9.  Effect of zopiclone on sleep quality, morning stiffness, widespread tenderness and pain and general discomfort in primary fibromyalgia patients. A double-blind randomized trial.

Authors:  M Grönblad; J Nykänen; Y Konttinen; E Järvinen; T Helve
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

10.  Metyrapone: an agent for melatonin as well as ACTH and cortisol secretion.

Authors:  K Brismar; S Werner; M Thorén; L Wetterberg
Journal:  J Endocrinol Invest       Date:  1985-04       Impact factor: 4.256

View more
  3 in total

1.  Mindfulness meditation alleviates fibromyalgia symptoms in women: results of a randomized clinical trial.

Authors:  Elizabeth Cash; Paul Salmon; Inka Weissbecker; Whitney N Rebholz; René Bayley-Veloso; Lauren A Zimmaro; Andrea Floyd; Eric Dedert; Sandra E Sephton
Journal:  Ann Behav Med       Date:  2015-06

Review 2.  Circadian rhythms and pain.

Authors:  Jacob R Bumgarner; William H Walker; Randy J Nelson
Journal:  Neurosci Biobehav Rev       Date:  2021-08-08       Impact factor: 9.052

3.  Obesity and sleepiness in women with fibromyalgia.

Authors:  Tânia Aparecida de Araújo; Maria Carliana Mota; Cibele Aparecida Crispim
Journal:  Rheumatol Int       Date:  2014-07-24       Impact factor: 2.631

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.